Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
Back to News
Carlsquare Equity Research interview with Biosergen
Equity Research
7 Mar 2024
Share
Tweet
Share
Herman Kuntscher
Equity Analyst
+46 70 585 99 32
herman.kuntscher@carlsquare.com
Niklas Elmhammer
Senior Equity Analyst
+46 70 898 39 59
niklas.elmhammer@carlsquare.com
Similar News
15 Jan 2025
Equity research Teneo AI: Preliminary figures above expectations
Equity Research
Teneo AI
08 Jan 2025
Equity Research, Zinzino: Blow away sales should lift profits
Equity Research
Zinzino
19 Dec 2024
Equity Research Nosa Plugs: Drug Delivery patent submitted
Equity Research
Nosa Plugs
11 Dec 2024
Investment Case Immunovia: Promising clinical data and incoming triggers
Equity Research
Immunovia
10 Dec 2024
Analyse Lokotech: Ny rammeavtale for forhåndsbestilling av Hashblades
Equity Research
Lokotech